Steven M. Paul - 09 Feb 2023 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
CSO and President of R&D, Director
Signature
/s/ Troy Ignelzi, Attorney-in-fact
Issuer symbol
KRTX
Transactions as of
09 Feb 2023
Transactions value $
$0
Form type
4
Filing time
13 Feb 2023, 15:15:43
Previous filing
05 Jan 2023
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Gift $0 -106K -100% $0.00* 0 27 May 2022 Spouse (Jann E. Paul GRAT I)
transaction KRTX Common Stock Gift $0 +106K $0.00 106K 27 May 2022 Spouse (Jann E. Paul Revocable Trust)
transaction KRTX Common Stock Gift $0 -106K -100% $0.00* 0 31 May 2022 Spouse (Jann E. Paul Revocable Trust)
transaction KRTX Common Stock Gift $0 +106K $0.00 106K 31 May 2022 Spouse (Jann E. Paul GRAT III)
transaction KRTX Common Stock Award $0 +11.4K $0.00 11.4K 09 Feb 2023 Direct F1
holding KRTX Common Stock 2.36K 09 Feb 2023 The Steven M. Paul Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (Right to Buy) Award $0 +22.8K $0.00 22.8K 09 Feb 2023 Common Stock 22.8K $187.26 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Comprised of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest annually in four 25% installments commencing on February 9, 2024, subject to continued service through such dates.
F2 25% of this option shall vest on February 9, 2024, and the remaining 75% shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates.